PVR and prostate carcinoma: Zhao Zhao H H Ma Ma J J Lei Lei T T The bispecific anti-CD3 x anti-CD155 antibody mediates T cell immunotherapy for human prostate cancer The bispecific anti-CD3 x anti-CD155 antibody mediates T cell immunotherapy for human prostate cancer Invest New Drugs Invest New Drugs 2019 2019 37 37 810 810 817 817 supplied-pmid 30374653?